Alexion

Alexion is a global biopharmaceutical company that focuses on developing and delivering life-transforming therapies for patients with severe and rare diseases. The company was founded in 1992 and is known for its development of innovative monoclonal antibody drugs. One of their most well-known drugs is Soliris (eculizumab), which is used to treat paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Alexion also focuses on developing therapies for other rare and devastating diseases, such as generalized myasthenia gravis and neuromyelitis optica spectrum disorder.